P. Gandhi

发表

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

S. Solomon, M. Sweetser, Y. Parman, 2018, The New England journal of medicine.

Rapid progression of familial amyloidotic polyneuropathy

B. Bettencourt, W. Litchy, P. Dyck, 2015, Neurology.

Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia

J. Gabrilove, H. Kantarjian, T. Kovacsovics, 2012, Leukemia & lymphoma.

HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein.

P. Gandhi, Kristine Y Chan, Elizabeth S Boucher, 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Effects of Angiotensin Converting Enzyme Inhibitors on Thrombotic Mediators: Potential Clinical Implications

P. Gandhi, S. Kothari, M. K. Le, 2003, Journal of Thrombosis and Thrombolysis.

Possible Mechanisms of Aspirin Resistance

P. Gandhi, Josie A. Cambria-Kiely, 2002, Journal of Thrombosis and Thrombolysis.

A Synopsis of the Clinical Uses of Argatroban

P. Gandhi, Mubina Moledina, Mehdi Chakir, 2001, Journal of thrombosis and thrombolysis.

Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.

M. Matthews, P. Gandhi, P. Belliveau, 2007, Clinical therapeutics.

A Review of the Clinical Uses of Ximelagatran in Thrombosis Syndromes

P. Gandhi, Elizabeth A. Bergsrud, 2003, Journal of Thrombosis and Thrombolysis.

Platelet Inhibitors in Non-ST-Segment Elevation Acute Coronary Syndromes and Percutaneous Coronary Intervention: Glycoprotein IIb/IIIa Inhibitors, Clopidogrel, or Both?

J. Donovan, P. Gandhi, Matthew A. Silva, 2006, Vascular health and risk management.

Polymorphism Induced Sensitivity to Warfarin: A Review of the Literature

P. Gandhi, A. J. Gardner, Michael P. Palkimas Jr, 2003, Journal of Thrombosis and Thrombolysis.

Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide

A. Ho, P. Mcsweeney, P. Gandhi, 2011, Bone Marrow Transplantation.

Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide

A. Ho, P. Mcsweeney, G. Calandra, 2011, Bone Marrow Transplantation.

Drug-Induced Thrombocytopenia in the Coronary Care Unit

P. Gandhi, Nicole M Patnode, 2000, Journal of Thrombosis and Thrombolysis.

G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT

E. Jacobsen, G. Calandra, P. Gandhi, 2013, Bone Marrow Transplantation.

Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

N. Russell, B. Shaw, P. Gandhi, 2011, Bone Marrow Transplantation.

Possible mechanisms of drug-induced aspirin and clopidogrel resistance

P. Gandhi, W. S. Schroeder, Linda Ghobrial, 2006, Journal of Thrombosis and Thrombolysis.

CD40 Ligand: A Novel Target in the Fight against Cardiovascular Disease

P. Gandhi, Diana Vishnevetsky, Vladimir A Kiyanista, 2004, The Annals of pharmacotherapy.

Emergency management of hemorrhagic complications in the era of glycoprotein IIb/IIIa receptor antagonists, clopidogrel, low molecular weight heparin, and third-generation fibrinolytic agents

P. Gandhi, W. S. Schroeder, 2003, Current cardiology reports.

Aspirin Resistance and Genetic Polymorphisms

P. Gandhi, Josie A. Cambria-Kiely, 2002, Journal of Thrombosis and Thrombolysis.

Myocardial infarction in an adolescent taking Adderall.

P. Gandhi, Maichi T. Tran, T. C. Tu, 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Matthew A Silva, G. Tataronis, P. Gandhi, 2006, Clinical therapeutics.

Pharmacokinetics and Pharmacodynamics of Low-Molecular-Weight Heparins and Glycoprotein IIb/IIIa Receptor Antagonists in Renal Failure

Brian S. Smith, P. Gandhi, 2001, Journal of Thrombosis and Thrombolysis.

Assessment of Eptifibatide Dosing in Renal Impairment Before and After In-Service Education Provided by Pharmacists

J. Donovan, P. Gandhi, A. Forrest, 2007, Journal of managed care pharmacy : JMCP.

Sirolimus-eluting coronary stent.

P. Gandhi, Payal R. Patel, Diana Vishnevetsky, 2004, American Journal of Health-System Pharmacy.

Brian S. Smith, G. Tataronis, P. Gandhi, 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Patisiran, an Investigational RNAi Therapeutic for Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy: Results from the Phase 3 APOLLO study (CT.001)

M. Sweetser, P. Dyck, J. Gollob, 2018 .

Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease

J. Ockene, M. Rosal, I. Ockene, 2010, Cholesterol.

Clinical Study Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-LoweringMedication Adherence among Patients with Coronary Heart Disease

J. Ockene, M. Rosal, I. Ockene, 2017 .

Antifactor Xa Levels in Four Patients with Burn Injuries Who Received Enoxaparin to Prevent Venous Thromboembolism

Brian S. Smith, P. Angood, P. Gandhi, 2004, Pharmacotherapy.

Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient.

K. Ramaswamy, P. Gandhi, Amy L. Rivera, 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

M. Sweetser, Y. Parman, P. Dyck, 2018, The New England journal of medicine.

Platelet Inhibitors in Non-ST-Segment Elevation Acute Coronary Syndromes and Percutaneous Coronary Intervention: Glycoprotein IIb/IIIa Inhibitors, Clopidogrel, or Both?

J. Donovan, P. Gandhi, Matthew A. Silva, 2006, Vascular health and risk management.